These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 25588587)

  • 1. Intravenous iron isomaltoside 1000 administered by high single-dose infusions or standard medical care for the treatment of fatigue in women after postpartum haemorrhage: study protocol for a randomised controlled trial.
    Holm C; Thomsen LL; Norgaard A; Langhoff-Roos J
    Trials; 2015 Jan; 16():5. PubMed ID: 25588587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous iron isomaltoside treatment of women suffering from severe fatigue after postpartum hemorrhage.
    Holm C; Thomsen LL; Langhoff-Roos J
    J Matern Fetal Neonatal Med; 2019 Sep; 32(17):2797-2804. PubMed ID: 29558233
    [No Abstract]   [Full Text] [Related]  

  • 3. Single-dose intravenous iron infusion or oral iron for treatment of fatigue after postpartum haemorrhage: a randomized controlled trial.
    Holm C; Thomsen LL; Norgaard A; Langhoff-Roos J
    Vox Sang; 2017 Apr; 112(3):219-228. PubMed ID: 28198084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous iron treatment in the puerperium.
    Holm C
    Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy: The PROFOUND Trial.
    Birgegård G; Henry D; Glaspy J; Chopra R; Thomsen LL; Auerbach M
    Pharmacotherapy; 2016 Apr; 36(4):402-14. PubMed ID: 26927900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous iron isomaltoside versus oral iron supplementation for treatment of iron deficiency in pregnancy: protocol for a randomised, comparative, open-label trial.
    Markova V; Hansen R; Thomsen LL; Pinborg A; Moos T; Holm C
    Trials; 2020 Aug; 21(1):742. PubMed ID: 32843079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose intravenous iron infusion versus red blood cell transfusion for the treatment of severe postpartum anaemia: a randomized controlled pilot study.
    Holm C; Thomsen LL; Norgaard A; Langhoff-Roos J
    Vox Sang; 2017 Feb; 112(2):122-131. PubMed ID: 28010050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous iron isomaltoside improves hemoglobin concentration and iron stores in female iron-deficient blood donors: a randomized double-blind placebo-controlled clinical trial.
    Gybel-Brask M; Seeberg J; Thomsen LL; Johansson PI
    Transfusion; 2018 Apr; 58(4):974-981. PubMed ID: 29424441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease.
    Wikström B; Bhandari S; Barany P; Kalra PA; Ladefoged S; Wilske J; Thomsen LL
    J Nephrol; 2011; 24(5):589-96. PubMed ID: 21240875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron concentration in breast milk normalised within one week of a single high-dose infusion of iron isomaltoside in randomised controlled trial.
    Holm C; Thomsen LL; Norgaard A; Markova V; Michaelsen KF; Langhoff-Roos J
    Acta Paediatr; 2017 Feb; 106(2):256-260. PubMed ID: 27883237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol and baseline data for a prospective open-label explorative randomized single-center comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD).
    Ziedan A; Bhandari S
    Trials; 2019 Apr; 20(1):194. PubMed ID: 30947751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NIMO-CKD-UK: a real-world, observational study of iron isomaltoside in patients with iron deficiency anaemia and chronic kidney disease.
    Kalra PA; Bhandari S; Spyridon M; Davison R; Lawman S; Mikhail A; Reaich D; Pritchard N; McCafferty K; Moore J
    BMC Nephrol; 2020 Dec; 21(1):539. PubMed ID: 33302891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: a randomised controlled trial.
    Perelló MF; Coloma JL; Masoller N; Esteve J; Palacio M
    BJOG; 2014 May; 121(6):706-13. PubMed ID: 24423186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose intravenously administered iron versus orally administered iron in blood donors with iron deficiency: study protocol for a randomised, controlled trial.
    Macher S; Drexler C; Lindenau I; Sareban N; Schlenke P; Amrein K
    Trials; 2016 Oct; 17(1):527. PubMed ID: 27793204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial.
    Bhandari S; Kalra PA; Berkowitz M; Belo D; Thomsen LL; Wolf M
    Nephrol Dial Transplant; 2021 Jan; 36(1):111-120. PubMed ID: 32049331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative intravenously administered iron sucrose versus postoperative orally administered iron to treat post-bariatric abdominoplasty anaemia (ISAPA): the study protocol for a randomised controlled trial.
    Montano-Pedroso JC; Garcia EB; Novo NF; Veiga DF; Ferreira LM
    Trials; 2016 Apr; 17():196. PubMed ID: 27068478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous versus oral iron therapy for postpartum anaemia.
    Bhandal N; Russell R
    BJOG; 2006 Nov; 113(11):1248-52. PubMed ID: 17004982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial.
    Jose A; Mahey R; Sharma JB; Bhatla N; Saxena R; Kalaivani M; Kriplani A
    BMC Pregnancy Childbirth; 2019 Feb; 19(1):54. PubMed ID: 30717690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of hypersensitivity reactions of intravenous iron: iron isomaltoside-1000 (Monofer
    Mulder MB; van den Hoek HL; Birnie E; van Tilburg AJP; Westerman EM
    Br J Clin Pharmacol; 2019 Feb; 85(2):385-392. PubMed ID: 30393904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of intravenous iron isomaltoside for correction of anaemia in patients with inflammatory bowel disease in everyday clinical practice.
    Stein J; Walper A; Klemm W; Farrag K; Aksan A; Dignass A
    Scand J Gastroenterol; 2018 Sep; 53(9):1059-1065. PubMed ID: 30222479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.